Detalhe da pesquisa
1.
Long-Term Outcomes of dMMR/MSI-H Rectal Cancer Treated With Anti-PD-1-Based Immunotherapy as Curative-Intent Treatment.
J Natl Compr Canc Netw
; 22(3)2024 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498975
2.
Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
Dis Colon Rectum
; 66(10): e996-e1005, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35485833
3.
Long-term outcomes of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection (IOCCRC): a randomized, multicenter, prospective, phase III trial.
Int J Surg
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652147
4.
Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients.
Eur J Cancer
; 192: 113253, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625240
5.
A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma.
Genes (Basel)
; 11(8)2020 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32784402
6.
Low prevalence of mismatch repair deficiency in Chinese colorectal cancers: a multicenter study.
Gastroenterol Rep (Oxf)
; 8(5): 399-403, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33163196